Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug Therapies

Table 1

Characteristics of the study participants by the chemotherapy, combined, and target therapy groups (𝑁=126).

	Therapy group			𝐹/𝜒^2	𝑃
	Chemotherapy; (𝑛=61); 𝑛 (%)	Combined therapy; (𝑛=35); 𝑛 (%)	Target therapy; (𝑛=30); 𝑛 (%)
Age (mean ± SD)	52.6 ± 11.2	56.5 ± 12.1	53.0 ± 9.9	1.5	0.23
Marital status				2.3	0.90
Single	11 (18.0)	8 (22.9)	4 (13.3)
Married	40 (65.6)	19 (54.3)	21 (70)
Widowed	7 (11.5)	5 (14.3)	3 (10)
Divorced	3 (4.9)	3 (8.6)	2 (6.7)
Currently working				1.7	0.44
No	29 (47.5)	21 (60)	14 (46.7)
Yes	32 (52.5)	14 (40)	16 (53.3)
Family Income
Insufficient	16 (26.2)	6 (17.1)	5 (16.7)
Sufficient	45 (73.8)	29 (82.9)	25 (83.3)
Religion				1.8	0.41
No	7 (11.5)	7 (20)	3 (10)
Yes	54 (88.5)	28 (80)	27 (90)
Diabetes				1.2	0.54
No	56 (91.8)	33 (94.3)	26 (86.7)
Yes	5 (8.2)	2 (5.7)	4 (13.3)
Hypertension				1.0	0.62
No	49 (80.3)	29 (82.9)	22 (73.3)
Yes	12 (19.7)	6 (17.1)	8 (26.7)
Coronary heart disease				0.4	0.80
No	55 (90.2)	31 (88.6)	28 (93.3)
Yes	6 (9.8)	4 (11.4)	2 (6.7)
Cancer stage				10.5	<0.01
I and II	43 (70.5)	13 (37.1)	19 (63.3)
III and IV	18 (29.5)	22 (62.9)	11 (36.7)
Lesion				3.7	0.45
Left	29 (47.5)	18 (51.4)	13 (43.3)
Right	30 (49.2)	15 (42.9)	13 (43.3)
Bilateral	2 (3.3)	2 (5.7)	4 (13.3)
Mastectomy				6.6	0.16
No	10 (16.4)	7 (20)	0 (0)
Partial	38 (62.3)	20 (57.1)	21 (70)
Total	13 (21.3)	8 (22.9)	9 (30)
Use of TCM
Before treatment				1.7	0.43
No	49 (79.0)	28 (82.4)	27 (90)
Yes	13 (21.0)	6 (17.6)	3 (10)
1 month after the start of treatment				11.4	<0.01
No	43 (69.4)	30 (88.2)	29 (96.7)
Yes	19 (30.6)	4 (11.8)	1 (3.3)
3 month after the start of treatment				10.3	<0.01
No	42 (68.9)	30 (85.7)	28 (93.3)
Yes	20 (31.1)	4 (14.3)	2 (6.7)

𝐹 and 𝜒² are the respective statistical values from the one-way ANOVA and chi-squared tests; the significance level was set at P < 0.05.